Maturity-onset diabetes of the young in a large Portuguese cohort

Sílvia Santos Monteiro1, Tiago da Silva Santos2, Liliana Fonseca2

  • 1Division of Endocrinology, Diabetes and Metabolism, Centro Hospitalar Universitário do Porto, Largo Professor Abel Salazar, 4099-001, Porto, Portugal. silviamsmonteiro@hotmail.com.

Acta Diabetologica
|October 8, 2022
PubMed
Abstract

Insights

Genetic testing is crucial for diagnosing monogenic diabetes, specifically Maturity-Onset Diabetes of the Young (MODY). This study identified common MODY-causing genes in a Portuguese cohort, aiding personalized treatment strategies.

Area of Science:

  • Endocrinology
  • Genetics
  • Diabetes Research

Background:

  • Monogenic diabetes, particularly Maturity-Onset Diabetes of the Young (MODY), is often underdiagnosed.
  • Autosomal dominant inheritance characterizes these forms of diabetes.
  • Genetic evaluation is key to identifying specific MODY subtypes.

Purpose of the Study:

  • To describe the clinical and molecular characteristics of a Portuguese cohort with suspected monogenic diabetes.
  • To identify prevalent MODY-causing genes within this cohort.
  • To emphasize the role of genetic testing in MODY diagnosis and management.

Main Methods:

  • Retrospective cohort study of patients with positive MODY genetic testing (2015-2021).
  • Utilized automatic sequencing and next-generation sequencing.
  • Described clinical and molecular data of identified individuals and family members.

Main Results:

  • Eighty individuals were included: 55 with pathogenic variants and 25 family members.
  • Median age at diagnosis was 23 years; median HbA1c was 6.5%.
  • HNF1A (40%), GCK (34%), and HNF4A (13%) were the most frequent mutated genes. Ten novel variants were identified.

Conclusions:

  • Genetic testing is vital for accurate MODY diagnosis and subtyping.
  • Identifying specific genetic mutations allows for tailored treatment and follow-up.
  • This study underscores the importance of genetic screening in suspected monogenic diabetes cases.

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.7K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.0K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.1K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
662
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
339
Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
269